Sporos Bioventures, LLC is a private biotechnology company focused on transforming the drug development process across oncology through its portfolio approach.
Sporos Bioventures owns equity interests in several biopharma entities: Tvardi Therapeutics, Asylia Therapeutics, and Sporos BioDiscovery.
Contact Us
Sporos Bioventures
3139 West Holcombe Blvd
Houston, TX 77025
United States
Alex Cranberg, M.B.A.
Founder, Aspect Energy
Rachel Humphrey, M.D.
CEO, Normunity
Harold Levy
Co-CIO, Iridian Asset Management
Peter Feinberg
Founding Partner, Boxcar Partners